Continuation of trastuzumab beyond disease progression is feasible and safe in patients with metastatic breast cancer: a retrospective analysis of 80 cases by the hellenic cooperative oncology group.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples